ArticleAnnals of nuclear medicine2024

Comparison of PET/CT-based eligibility according to VISION and TheraP trial criteria in end-stage prostate cancer patients undergoing radioligand therapy.

Kerstin Michalski et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.